How strong is the evidence specifically for knee osteoarthritis vs osteoporosis?

The short version: the evidence for turmeric helping knee osteoarthritis is modest and formulation-dependent; the evidence for osteoporosis is essentially absent from these records.

The retrieved studies are almost entirely about knee osteoarthritis. A 2025 network meta-analysis of 17 RCTs found that all turmeric preparation classes reduced pain versus placebo, but most estimates had low to very low certainty [2]. A 2021 non-inferiority trial showed bioavailable curcumin matched paracetamol for pain relief over 6 weeks, with fewer side effects [3]. A 2026 RCT using a topical curcumin gel also showed pain improvement over placebo in 28 days [1]. These are real but modest signals.

For osteoporosis, the retrieval contains exactly one animal study. In ovariectomized rats, PLGA nanoparticles loaded with curcumin improved bone mineral density from 0.05 g/cm² to 0.10 g/cm², still far below the sham group's 0.30 g/cm² [4]. That is a rat model with a nanoparticle formulation not available to consumers. No human trial on osteoporosis appears in these records.

The gap is not subtle. If you have knee osteoarthritis, a bioavailable curcumin formulation may modestly reduce pain. If you are concerned about osteoporosis, these records provide no basis to expect any benefit from turmeric.

My call: the evidence for knee osteoarthritis is weak but present; the evidence for osteoporosis is absent from these records. Confidence: high on the gap, low on the knee OA benefit.